Sarsys Balance Sheet Health
Financial Health criteria checks 5/6
Sarsys has a total shareholder equity of SEK914.0K and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK48.6M and SEK47.7M respectively.
Key information
0%
Debt to equity ratio
SEK 0
Debt
Interest coverage ratio | n/a |
Cash | SEK 3.99m |
Equity | SEK 914.00k |
Total liabilities | SEK 47.67m |
Total assets | SEK 48.58m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: SARS's short term assets (SEK26.6M) do not cover its short term liabilities (SEK40.6M).
Long Term Liabilities: SARS's short term assets (SEK26.6M) exceed its long term liabilities (SEK7.0M).
Debt to Equity History and Analysis
Debt Level: SARS is debt free.
Reducing Debt: SARS has no debt compared to 5 years ago when its debt to equity ratio was 40%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable SARS has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: SARS is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 67% per year.